Skip to main content
. 2017 May 12;7:453–464. doi: 10.1016/j.omtn.2017.05.006

Figure 6.

Figure 6

Decreased Expression of miR-1290 Promotes Tumor Sensitivity to 5-FU In Vivo

HCT116-5Fures cell lines stably expressing miR-1290 inhibitor (anti-miR-1290) or vector control (NC) were subcutaneously injected into nude mice. After 3 weeks, 5-FU (50 mg·kg−1·d−1) or the same volume of saline were intraperitoneally injected for five consecutive days per week for 4 weeks. (A) Nude mice were euthanized on day 49, and tumors were immediately peeled off. (B) Tumor size was measured on days 4, 7, 14, 21, 28, 35, 42, and 49 with Vernier calipers (mean ± SD; n = 5). *p < 0.05, **p < 0.01. (C) Western blot analysis of representative excised tumor mass using the indicated antibodies. (D) qRT-PCR analysis of miR-1290 expression from representative excised tumor mass (**p < 0.01).